JB Chemicals Receives Clean Bill from USFDA for Panoli Facility

JB Chemicals & Pharmaceuticals has announced that its formulations manufacturing facility in Panoli, Gujarat, has successfully passed a USFDA inspection with no observations. The audit, conducted from March 3 to March 7, 2025, resulted in no Form 483 being issued, reflecting the facility's adherence to high-quality standards. This achievement underscores JB Chemicals' commitment to quality and compliance, enhancing its reputation in the pharmaceutical industry. The company's shares rose following the announcement, highlighting investor confidence in its operations.

 

Source: Business Standard